실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

9,268+프로그램
35+FDA 승인
4,079+모집 중
ADC 1068·Antibody 5456·CGT 2744차세대 추천 →·Data Tier →
9268프로그램35FDA 승인
0오늘 방문
572누적 방문
8122갱신 대기S–CData TierS/A/B차세대1068HER2 breast5456Antibody2744CGT→Psoriasis→NSCLC35FDA 승인
피드Data Tier차세대

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · Ebglyss혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

최근 활동

RSS →

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
다음 갱신 D-12 · 마지막 7월 13일
AntibodystaleInnoventPhase 2

Sintilimab+Pegaspargase (Sintilimab+Pegaspargase)

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type · Natural Killer/T-Cell Lymphoma, Nasal an

#NaturalKillerT-CellLymphomaNasal#Antibody#Phase2#항체#면역항체+5
임상시험 8상태 RECRUITING
CGTBiologicstaleShanghai Yunying Medical Techno…Phase 1

R130 (Recombinant oncolytic herpes simplex virus type Ⅰ, Recombinant oncolytic herpes simplex virus type Ⅰ (R130))

Osteosarcoma; Sarcoma · Osteosarcoma

#Osteosarcoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 8상태 ACTIVE
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, Daratumumab, dexamethasone, ixazomib, pomalidomide)

Relapsed Refractory Multiple Myeloma · FRα

#FR#Antibody#Phase2#항체#면역항체+3
임상시험 8상태 ACTIVE
ADCBiologicstalePfizerPreclinical

Antibody Drug Conjugate Chemotherapeutic (Antibody Drug Conjugate Chemotherapeutic)

CD33 Positive Acute Myelogenous Leukemia · CD33

#CD33#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 51%임상시험 8상태 ACTIVE
ADCBiologicstaleMedImmune LLCPhase 1

BL22 immunotoxin (BL22 immunotoxin)

Leukemia; Lymphoma · Leukemia

#Leukemia#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 0%임상시험 8상태 ACTIVE
AntibodystaleRochePhase 2

atezolizumab (Tecentriq, Atezolizumab and Talazoparib)

Lymphoma, Non-Hodgkin; Multiple Myeloma · Lymphoma, Non-Hodgkin

#LymphomaNon-Hodgkin#Antibody#Phase2#항체#면역항체+5
효능 ORR 0%임상시험 8상태 RECRUITING
ADCBiologicGenmabPhase 3

Rina-S (Rina-S)

High Grade Epithelial Ovarian Cancer; High Grade Serous Ovarian Cancer · Platinum-resistant Ovarian Cancer

#Platinum-resistantOvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 8상태 RECRUITING
ADCBiologicstaleRegeneron PharmaceuticalsPhase 2

vidutolimod (vidutolimod)

Merkel Cell Carcinoma; Cutaneous Squamous Cell Carcinoma · Merkel Cell Carcinoma

#MerkelCellCarcinoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 56%임상시험 8상태 DISCONTINUED
AntibodystaleJin-hong ChenPhase 2

Cadonilimab+regorafenib (Cadonilimab+regorafenib)

Advanced Hepatocellular Carcinoma · Advanced Hepatocellular Carcinoma

#AdvancedHepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 8상태 ACTIVE
ADCBiologicstaleRemeGen Co., Ltd.Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, 6 cycle RC48 and JS001)

Urology · Urology

#Urology#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 8상태 RECRUITING
ADCBiologicstaleGlaxoSmithKlinePhase 2

GSK5764227 (GSK5764227)

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma · Recurrent/Metastatic Head and Neck Squam

#RecurrentMetastaticHeadandNeckSq#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 8상태 RECRUITING
ADCBiologicstaleAbbViePhase 2

ABT-414 (ABT-414)

Malignant Glioma; Glioblastoma Multiforme · Malignant Glioma

#MalignantGlioma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 14.3%임상시험 8상태 ACTIVE
ADCBiologicstaleBayerPhase 1

BAY94-9343 (BAY94-9343)

Neoplasms · Oncology

#Oncology#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 7.2%임상시험 8상태 ACTIVE
ADCBiologicstaleDaiichi SankyoPhase 1

Valemetostat tosylate (Valemetostat tosylate)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 43.7%임상시험 8상태 RECRUITING
ADCBiologicstaleGenmabApproved

TIVDAK (TIVDAK)

Cervical Cancer · Cervical Cancer

#CervicalCancer#ADC#Approved#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 23.8%임상시험 8상태 RECRUITING
ADCBiologicstaleJanssen Research & Development,…Phase 1

JNJ-78278343 (JNJ-78278343)

Prostatic Neoplasms · Prostatic Neoplasms

#ProstaticNeoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 8상태 RECRUITING
CGTBiologicHebei Senlang Biotechnology Inc…Phase 1

Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells (Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells)

19 and 22+ B Cell Hematologic Tumors; 19 and 20+ B Cell Hematologic Tumors · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 8상태 RECRUITING
CGTBiologicstaleTILT Biotherapeutics Ltd.Phase 1

Oncolytic virus Plus Anti-PD1 and Chemotherapy (Oncolytic virus Plus Anti-PD1 and Chemotherapy)

Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 8상태 RECRUITING
ADCBiologicstaleMiltenyi Biomedicine GmbHPhase 2

MB-CART2019.1 (MB-CART2019.1)

Diffuse Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 8상태 RECRUITING
CGTBiologicStephan Grupp MD PhDPhase 1

CART123 (Anti-CD123 LV redirected T cells, Anti-CD123 LV redirected T cells (CART123))

Acute Myeloid Leukemia (AML) · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 8상태 RECRUITING
CGTAAVBHOTFDACuratedFDABiologicSpark TherapeuticsHuman RPE65 cDNAApproved

voretigene neparvovec (Luxturna, AAV2-hRPE65v2, voretigene neparvovec-rzyl)

Inherited retinal dystrophy due to confirmed biallelic RPE65 mutations · RPE65 (AAV2)

#RPE65AAV2#CGT#Approved#FDA승인#바이오모아추천+5
임상시험 7상태 APPROVED
CGTAAVBHOTFDACuratedFDABiologicCSL BehringFactor IX Padua variant (hy…Approved

etranacogene dezaparvovec (Hemgenix, AMT-061, CSL222, etranacogene dezaparvovec-drlb)

Hemophilia B (congenital Factor IX deficiency) in adults · Factor IX (AAV5 Padua)

#FactorIXAAV5Padua#CGT#Approved#FDA승인#바이오모아추천+5
임상시험 7상태 APPROVED
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

CD33 CAR-NK cell (CD33 CAR-NK cell)

AML, Adult; Minimal Residual Disease · CD33

#CD33#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 7상태 ACTIVE
ADCBiologicstaleHoffmann-La RochePhase 2

Camonsertib (Camonsertib)

Solid Tumors · Solid Tumors

#SolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 33.3%임상시험 7상태 RECRUITING
ADCBiologicstalepharmaand GmbHPhase 1

Rucaparib Camsylate (Rucaparib Camsylate)

BRCA1 Gene Mutation; BRCA2 Gene Mutation · BRCA1 Gene Mutation

#BRCA1GeneMutation#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 9%임상시험 7상태 ACTIVE

39 / 167 페이지

← 이전다음 →
전체 9,268개 프로그램 보기